Improving the Gastrointestinal Stability of Linaclotide

[Image: see text] High susceptibility to proteolytic degradation in the gastrointestinal tract limits the therapeutic application of peptide drugs in gastrointestinal disorders. Linaclotide is an orally administered peptide drug for the treatment of irritable bowel syndrome with constipation (IBS-C)...

Descripción completa

Detalles Bibliográficos
Autores principales: Braga Emidio, Nayara, Tran, Hue N. T., Andersson, Asa, Dawson, Philip E., Albericio, Fernando, Vetter, Irina, Muttenthaler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237258/
https://www.ncbi.nlm.nih.gov/pubmed/33979161
http://dx.doi.org/10.1021/acs.jmedchem.1c00380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237258/
https://www.ncbi.nlm.nih.gov/pubmed/33979161
http://dx.doi.org/10.1021/acs.jmedchem.1c00380

Ejemplares similares